2023-09-252024-09-302024-09-30false15161532LNC MEDICAL LTD2025-06-04falseiso4217:GBPxbrli:pure151615322023-09-25151615322024-09-30151615322023-09-252024-09-30151615322023-09-24151615322023-09-24151615322023-09-242023-09-2415161532bus:SmallEntities2023-09-252024-09-3015161532bus:AuditExempt-NoAccountantsReport2023-09-252024-09-3015161532bus:FullAccounts2023-09-252024-09-3015161532bus:PrivateLimitedCompanyLtd2023-09-252024-09-3015161532core:WithinOneYear2024-09-3015161532core:AfterOneYear2024-09-3015161532core:WithinOneYear2023-09-2415161532core:AfterOneYear2023-09-2415161532core:ShareCapital2024-09-3015161532core:SharePremium2024-09-3015161532core:RevaluationReserve2024-09-3015161532core:OtherReservesSubtotal2024-09-3015161532core:RetainedEarningsAccumulatedLosses2024-09-3015161532core:ShareCapital2023-09-2415161532core:SharePremium2023-09-2415161532core:RevaluationReserve2023-09-2415161532core:OtherReservesSubtotal2023-09-2415161532core:RetainedEarningsAccumulatedLosses2023-09-2415161532core:LandBuildings2024-09-3015161532core:PlantMachinery2024-09-3015161532core:Vehicles2024-09-3015161532core:FurnitureFittings2024-09-3015161532core:OfficeEquipment2024-09-3015161532core:NetGoodwill2024-09-3015161532core:IntangibleAssetsOtherThanGoodwill2024-09-3015161532core:ListedExchangeTraded2024-09-3015161532core:UnlistedNon-exchangeTraded2024-09-3015161532core:LandBuildings2023-09-2415161532core:PlantMachinery2023-09-2415161532core:Vehicles2023-09-2415161532core:FurnitureFittings2023-09-2415161532core:OfficeEquipment2023-09-2415161532core:NetGoodwill2023-09-2415161532core:IntangibleAssetsOtherThanGoodwill2023-09-2415161532core:ListedExchangeTraded2023-09-2415161532core:UnlistedNon-exchangeTraded2023-09-2415161532core:LandBuildings2023-09-252024-09-3015161532core:PlantMachinery2023-09-252024-09-3015161532core:Vehicles2023-09-252024-09-3015161532core:FurnitureFittings2023-09-252024-09-3015161532core:OfficeEquipment2023-09-252024-09-3015161532core:NetGoodwill2023-09-252024-09-3015161532core:IntangibleAssetsOtherThanGoodwill2023-09-252024-09-3015161532core:ListedExchangeTraded2023-09-252024-09-3015161532core:UnlistedNon-exchangeTraded2023-09-252024-09-3015161532core:MoreThanFiveYears2023-09-252024-09-3015161532core:Non-currentFinancialInstruments2024-09-3015161532core:Non-currentFinancialInstruments2023-09-2415161532dpl:CostSales2023-09-252024-09-3015161532dpl:DistributionCosts2023-09-252024-09-3015161532core:LandBuildings2023-09-252024-09-3015161532core:PlantMachinery2023-09-252024-09-3015161532core:Vehicles2023-09-252024-09-3015161532core:FurnitureFittings2023-09-252024-09-3015161532core:OfficeEquipment2023-09-252024-09-3015161532dpl:AdministrativeExpenses2023-09-252024-09-3015161532core:NetGoodwill2023-09-252024-09-3015161532core:IntangibleAssetsOtherThanGoodwill2023-09-252024-09-3015161532dpl:GroupUndertakings2023-09-252024-09-3015161532dpl:ParticipatingInterests2023-09-252024-09-3015161532dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-252024-09-3015161532core:ListedExchangeTraded2023-09-252024-09-3015161532dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-252024-09-3015161532core:UnlistedNon-exchangeTraded2023-09-252024-09-3015161532dpl:CostSales2023-09-242023-09-2415161532dpl:DistributionCosts2023-09-242023-09-2415161532core:LandBuildings2023-09-242023-09-2415161532core:PlantMachinery2023-09-242023-09-2415161532core:Vehicles2023-09-242023-09-2415161532core:FurnitureFittings2023-09-242023-09-2415161532core:OfficeEquipment2023-09-242023-09-2415161532dpl:AdministrativeExpenses2023-09-242023-09-2415161532core:NetGoodwill2023-09-242023-09-2415161532core:IntangibleAssetsOtherThanGoodwill2023-09-242023-09-2415161532dpl:GroupUndertakings2023-09-242023-09-2415161532dpl:ParticipatingInterests2023-09-242023-09-2415161532dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-242023-09-2415161532core:ListedExchangeTraded2023-09-242023-09-2415161532dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-242023-09-2415161532core:UnlistedNon-exchangeTraded2023-09-242023-09-2415161532core:NetGoodwill2024-09-3015161532core:IntangibleAssetsOtherThanGoodwill2024-09-3015161532core:LandBuildings2024-09-3015161532core:PlantMachinery2024-09-3015161532core:Vehicles2024-09-3015161532core:FurnitureFittings2024-09-3015161532core:OfficeEquipment2024-09-3015161532core:AfterOneYear2024-09-3015161532core:WithinOneYear2024-09-3015161532core:ListedExchangeTraded2024-09-3015161532core:UnlistedNon-exchangeTraded2024-09-3015161532core:ShareCapital2024-09-3015161532core:SharePremium2024-09-3015161532core:RevaluationReserve2024-09-3015161532core:OtherReservesSubtotal2024-09-3015161532core:RetainedEarningsAccumulatedLosses2024-09-3015161532core:NetGoodwill2023-09-2415161532core:IntangibleAssetsOtherThanGoodwill2023-09-2415161532core:LandBuildings2023-09-2415161532core:PlantMachinery2023-09-2415161532core:Vehicles2023-09-2415161532core:FurnitureFittings2023-09-2415161532core:OfficeEquipment2023-09-2415161532core:AfterOneYear2023-09-2415161532core:WithinOneYear2023-09-2415161532core:ListedExchangeTraded2023-09-2415161532core:UnlistedNon-exchangeTraded2023-09-2415161532core:ShareCapital2023-09-2415161532core:SharePremium2023-09-2415161532core:RevaluationReserve2023-09-2415161532core:OtherReservesSubtotal2023-09-2415161532core:RetainedEarningsAccumulatedLosses2023-09-2415161532core:NetGoodwill2023-09-2415161532core:IntangibleAssetsOtherThanGoodwill2023-09-2415161532core:LandBuildings2023-09-2415161532core:PlantMachinery2023-09-2415161532core:Vehicles2023-09-2415161532core:FurnitureFittings2023-09-2415161532core:OfficeEquipment2023-09-2415161532core:AfterOneYear2023-09-2415161532core:WithinOneYear2023-09-2415161532core:ListedExchangeTraded2023-09-2415161532core:UnlistedNon-exchangeTraded2023-09-2415161532core:ShareCapital2023-09-2415161532core:SharePremium2023-09-2415161532core:RevaluationReserve2023-09-2415161532core:OtherReservesSubtotal2023-09-2415161532core:RetainedEarningsAccumulatedLosses2023-09-2415161532core:AfterOneYear2023-09-252024-09-3015161532core:WithinOneYear2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:CostValuation2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-252024-09-3015161532core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3015161532core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3015161532core:Non-currentFinancialInstrumentscore:CostValuation2023-09-2415161532core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-2415161532core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-2415161532core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-2415161532core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-2415161532core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-2415161532core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-2415161532core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-2415161532core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-2415161532bus:Director12023-09-252024-09-3015161532bus:Director22023-09-252024-09-30

LNC MEDICAL LTD

Registered Number
15161532
(England and Wales)

Unaudited Financial Statements for the Period ended
30 September 2024

LNC MEDICAL LTD
Company Information
for the period from 25 September 2023 to 30 September 2024

Directors

SEIFALIAN, Katharine Jane
SEIFALIAN, Said

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

15161532 (England and Wales)
LNC MEDICAL LTD
Balance Sheet as at
30 September 2024

Notes

2024

£

£

Fixed assets
Tangible assets3648
648
Current assets
Cash at bank and on hand54,486
54,486
Creditors amounts falling due within one year5(35,654)
Net current assets (liabilities)18,832
Total assets less current liabilities19,480
Net assets19,480
Capital and reserves
Called up share capital130
Profit and loss account19,350
Shareholders' funds19,480
The financial statements were approved and authorised for issue by the Board of Directors on 4 June 2025, and are signed on its behalf by:
SEIFALIAN, Said
Director
Registered Company No. 15161532
LNC MEDICAL LTD
Notes to the Financial Statements
for the period ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment50
2.Average number of employees

2024
Average number of employees during the year2
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions978978
At 30 September 24978978
Depreciation and impairment
Charge for year330330
At 30 September 24330330
Net book value
At 30 September 24648648
At 24 September 23--
4.Debtors: amounts due within one year
5.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables160
Taxation and social security5,091
Other creditors29,322
Accrued liabilities and deferred income1,081
Total35,654